
Covid-19: Pfizer to Cut Vaccine Production Time By 50%
American drugmaker Pfizer has said it plans to reduce the amount of time it takes to produce a batch of
American drugmaker Pfizer has said it plans to reduce the amount of time it takes to produce a batch of
The makers of Pfizer and BioNTech coronavirus vaccine said on Thursday that their vaccine is only slightly less effective against
WHO Director-General Tedros Adhanom Ghebreyesus has expressed concern about wealthy nations buying up the supply of vaccines and leaving none
The United Kingdom (UK) on Wednesday approved the Pfizer-BioNTech vaccine for the novel coronavirus disease, to be rolled out and
In terms of distribution, which is the foremost challenge in getting a vaccine across the world, the AstraZeneca vaccine will
According to reports, wealthier hospitals in the United States have started buying up expensive specialized freezers for Pfizer’s vaccine, raising
Meanwhile, African leaders have so far only welcomed news of the effective shots without obvious efforts to secure doses of
The Nigerian Markets Last Week for the week ended November 13, 2020. Stock Market The Nigerian Stock Exchange All-Share Index
The European Union has negotiated to buy up to 300 million doses of the breakthrough coronavirus vaccine developed by BioNTech
American multinational Pfizer today said early results from a trial of its coronavirus vaccine, developed in collaboration with German biotech
By clicking the Subscribe button, you confirm that you have read our Privacy Policy and consent to receive newsletters from us.
We uphold the highest standards of journalistic integrity and ethical reporting, ensuring that truth and transparency prevail in all our content.
Arbiterz profiles Nigerians creating livelihoods and building businesses and analyses the economic and political ideas that shape the opportunities and constraints they encounter.
brandstories@arbiterz.com
+234-1-4489262 | 1-454 8069
7th Floor, Mulliner Towers, 39, Alfred Rewane Road, Ikoyi, Lagos.
brandstories@arbiterz.com
brandstories@arbiterz.com
© Arbiterz 2025, All Rights Reserved. | Powered by ONMATECH.
Get notified about new articles